Literature DB >> 19417209

Thrombin-cleaved osteopontin regulates hemopoietic stem and progenitor cell functions through interactions with alpha9beta1 and alpha4beta1 integrins.

Jochen Grassinger1, David N Haylock, Melonie J Storan, Gemma O Haines, Brenda Williams, Genevieve A Whitty, Andrew R Vinson, Cheang Ly Be, Songhui Li, Esben S Sørensen, Patrick P L Tam, David T Denhardt, Dean Sheppard, Peter F Choong, Susan K Nilsson.   

Abstract

Osteopontin (OPN), a multifunctional acidic glycoprotein, expressed by osteoblasts within the endosteal region of the bone marrow (BM) suppresses the proliferation of hemopoietic stem and progenitor cells and also regulates their lodgment within the BM after transplantation. Herein we demonstrate that OPN cleavage fragments are the most abundant forms of this protein within the BM. Studies aimed to determine how hemopoietic stem cells (HSCs) interact with OPN revealed for the first time that murine and human HSCs express alpha(9)beta(1) integrin. The N-terminal thrombin cleavage fragment of OPN through its binding to the alpha(9)beta(1) and alpha(4)beta(1) integrins plays a key role in the attraction, retention, regulation, and release of hemopoietic stem and progenitor cells to, in, and from their BM niche. Thrombin-cleaved OPN (trOPN) acts as a chemoattractant for stem and progenitor cells, mediating their migration in a manner that involves interaction with alpha(9)beta(1) and alpha(4)beta(1) integrins. In addition, in the absence of OPN, there is an increased number of white blood cells and, specifically, stem and progenitor cells in the peripheral circulation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19417209     DOI: 10.1182/blood-2009-01-197988

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  82 in total

1.  Pre- and post-translational regulation of osteopontin in cancer.

Authors:  Pieter H Anborgh; Jennifer C Mutrie; Alan B Tuck; Ann F Chambers
Journal:  J Cell Commun Signal       Date:  2011-04-26       Impact factor: 5.782

2.  Ex vivo expansion of cord blood progenitors impairs their short-term and long-term repopulating activity associated with transcriptional dysregulation of signalling networks.

Authors:  T Holmes; F Yan; K-H Ko; R Nordon; E Song; T A O'Brien; A Dolnikov
Journal:  Cell Prolif       Date:  2012-03-20       Impact factor: 6.831

Review 3.  Molecular signaling of the epithelial to mesenchymal transition in generating and maintaining cancer stem cells.

Authors:  Gaoliang Ouyang; Zhe Wang; Xiaoguang Fang; Jia Liu; Chaoyong James Yang
Journal:  Cell Mol Life Sci       Date:  2010-03-18       Impact factor: 9.261

4.  Pharmacologic modulation of the calcium-sensing receptor enhances hematopoietic stem cell lodgment in the adult bone marrow.

Authors:  Ben S Lam; Cynthia Cunningham; Gregor B Adams
Journal:  Blood       Date:  2010-11-12       Impact factor: 22.113

5.  Vascular endothelial growth factor A (VEGF-A) induces endothelial and cancer cell migration through direct binding to integrin {alpha}9{beta}1: identification of a specific {alpha}9{beta}1 binding site.

Authors:  Saji Oommen; Shiv K Gupta; Nicholas E Vlahakis
Journal:  J Biol Chem       Date:  2010-11-11       Impact factor: 5.157

6.  The role of CD44 in fetal and adult hematopoietic stem cell regulation.

Authors:  Huimin Cao; Shen Y Heazlewood; Brenda Williams; Daniela Cardozo; Julie Nigro; Ana Oteiza; Susan K Nilsson
Journal:  Haematologica       Date:  2015-11-06       Impact factor: 9.941

Review 7.  Progress and obstacles towards generating hematopoietic stem cells from pluripotent stem cells.

Authors:  Jungmin Lee; Brad Dykstra; Robert Sackstein; Derrick J Rossi
Journal:  Curr Opin Hematol       Date:  2015-07       Impact factor: 3.284

Review 8.  Parsing the niche code: the molecular mechanisms governing hematopoietic stem cell adhesion and differentiation.

Authors:  E Camilla Forsberg; Stephanie Smith-Berdan
Journal:  Haematologica       Date:  2009-11       Impact factor: 9.941

9.  Splenic pooling and loss of VCAM-1 causes an engraftment defect in patients with myelofibrosis after allogeneic hematopoietic stem cell transplantation.

Authors:  Christina Hart; Sabine Klatt; Johann Barop; Gunnar Müller; Roland Schelker; Ernst Holler; Elisabeth Huber; Wolfgang Herr; Jochen Grassinger
Journal:  Haematologica       Date:  2016-08-04       Impact factor: 9.941

10.  Adhesion to osteopontin in the bone marrow niche regulates lymphoblastic leukemia cell dormancy.

Authors:  Benjamin Boyerinas; Maya Zafrir; Ali E Yesilkanal; Trevor T Price; Elizabeth M Hyjek; Dorothy A Sipkins
Journal:  Blood       Date:  2013-04-15       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.